Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hervé Dombret Pierre Fenaux Sylvie Chevret |
| Publication date | December 29, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |